Which agent is typically used to treat an acute gout attack?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

Which agent is typically used to treat an acute gout attack?

Explanation:
An acute gout attack is driven by a sudden inflammatory response to urate crystals, so the goals are rapid anti-inflammatory relief and pain control. An NSAID that inhibits prostaglandin synthesis, like indomethacin, quickly reduces joint inflammation and pain, making it a common first-line treatment for an acute flare. The other agents shown target uric acid levels over time rather than providing fast anti-inflammatory effects: allopurinol lowers uric acid production but isn’t used for immediate relief and can worsen the attack if started during the flare; probenecid increases uric acid excretion but doesn’t address acute inflammation; pegloticase degrades uric acid and is reserved for chronic, refractory gout. Therefore, indomethacin is the best choice for treating an acute gout attack.

An acute gout attack is driven by a sudden inflammatory response to urate crystals, so the goals are rapid anti-inflammatory relief and pain control. An NSAID that inhibits prostaglandin synthesis, like indomethacin, quickly reduces joint inflammation and pain, making it a common first-line treatment for an acute flare. The other agents shown target uric acid levels over time rather than providing fast anti-inflammatory effects: allopurinol lowers uric acid production but isn’t used for immediate relief and can worsen the attack if started during the flare; probenecid increases uric acid excretion but doesn’t address acute inflammation; pegloticase degrades uric acid and is reserved for chronic, refractory gout. Therefore, indomethacin is the best choice for treating an acute gout attack.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy